Tarchomin Pharmaceutical Works "Polfa" S.A.

Tweet this page
<
2024
>
Registration as it was on 19 Apr 2024
How to read and use this data card.
Download this datacard

Overview

Lobbying Costs

10,000€ - 24,999€

Financial year: Jan 2023 - Dec 2023

Lobbyists (Full time equivalent)

0.4 Fte (4)

Lobbyists with EP accreditation

0

High-level Commission meetings

0

Lobbying Costs over the years

  • Info

    Tarchomin Pharmaceutical Works "Polfa" S.A.   (TZF)

    EU Transparency Register

    316556891811-84 First registered on 19 Apr 2024

    Goals / Remit

    Polish generic pharmaceutical company, producer of APIs and FDFs critical for European and international markets. Company with 200 years of history in pharma business. The only polish penicillin's manufacturer, a strong player in antibiotics market, producer of human insulin, highly experienced in sterile production. We heavily invest in new state of the art production facility dedicated to hilgly potent drugs.

    Main EU files targeted

    EMA/528805/2023 Union list of critical medicines - version 1
    Vulnerabilities in critical medicines supply chains

    Address

    Head Office
    Fleminga 2
    Warszawa 03-176
    POLAND
    EU Office
    Fleminga 2
    Warszawa 03-176
    POLAND

    Website

    https://www.polfa-tarchomin.com.pl

  • People

    Total lobbyists declared

    4

    Employment timeLobbyists
    10%4

    Lobbyists (Full time equivalent)

    0.4

    Lobbyists with EP accreditation

    No lobbyists with EP accreditations

    Complementary Information

    4 people work in close cooperation with HEAR at data collection survey for the pilot phase of the critical medicines vulnerability analysis to collect necessary data and work as EDQM experts in working groups.
    Their percentage involvement regarding to full time job is estimated for 10%.

    Person in charge of EU relations

    Data not provided by Register Secretariat due to GDPR

    Person with legal responsibility

    Data not provided by Register Secretariat due to GDPR

  • Categories

    Category

    Companies & groups

  • Networking

    Affiliation

    EDQM

    Member organisations

    Małgorzata Stokrocka - Expert in EDQM Working Group
    Rafał Łunio - Expert in EDQM Working Group
    Monika Janicka - Expert in EDQM Working Group

  • Financial Data

    Interests represented

    Promotes their own interests or the collective interests of their members

    Closed financial year

    Jan 2023 - Dec 2023

    Lobbying costs for closed financial year

    10,000€ - 24,999€

    Major contributions in closed year

    None declared

    Intermediaries for closed year

    None declared

    Intermediaries for current year

    None declared

    Closed year Costs

    10,000€ - 24,999€

    Other financial info

    None declared

  • EU Structures

    Groups (European Commission)

    None declared

    Groups (European Parliament)

    N/A

    Communication activities

    https://www.ema.europa.eu/en/news/first-version-union-list-critical-medicines-agreed-help-avoid-potential-shortages-eu
    https://health.ec.europa.eu/health-emergency-preparedness-and-response-hera_en
    https://health.ec.europa.eu/health-emergency-preparedness-and-response-hera/overview/critical-medicines-alliance_en
    https://www.edqm.eu/en/groups-of-experts-and-working-parties

    Other activities

    None declared

  • Meetings

    Meetings

    None declared

Download this datacard